Connexin43 peptide, TAT-Cx43(266–283), selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

BACKGROUND: Malignant gliomas are the most frequent primary brain tumors and remain among the most incurable cancers. Although the role of the gap junction protein, connexin43 (Cx43), has been deeply investigated in malignant gliomas, no compounds have been reported with the ability to recapitulate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Jaraíz-Rodríguez, Myriam, Talaverón, Rocío, García-Vicente, Laura, Pelaz, Sara G, Domínguez-Prieto, Marta, Álvarez-Vázquez, Andrea, Flores-Hernández, Raquel, Sin, Wun Chey, Bechberger, John, Medina, José M, Naus, Christian C, Tabernero, Arantxa
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158688/
https://ncbi.nlm.nih.gov/pubmed/31883012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz243
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars